Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Список исп. литературыСкрыть список 1. Asenjo Lobos C, Komossa K, Rummel-Kluge C et al. Clozapine vs other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2010; 11. CD 006633. 2. Azorin J-M, Spiegel R, Remington G et al. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. Am J Psychiat 2001; 158: 1305–13. 3. Azorin J-M, Strub N, Loft H. A double-blind, controlled study sertindole versus risperidone in the treatment of moderate to severe schizophrenia. Int J Psychopharmacol 2006; 21: 49–56. 4. Barnett PG, Scott JY, Rosenheck RA. How do clinical trial compare to other patients with schizophrenia? Schizophr Res 2011; 130: 34–9. 5. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflict of interests in biomedical research: a systematic review. JAMA 2003; 289: 454–65. 6. Bowen J, Hirsch S. Recruitment rates and factors affected recruitment for a clinical trial of a putative anti-psychotic agent in the treatment of acute schizophrenia. Human Psychopharmacol 1992; 7: 337–41. 7. Bowden CL, Calabrese JR, Wallin BA et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacol Bull 1995; 31: 103–9. 8. Carpenter WT, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiat 1988; 145: 578–83. 9. Conley RR, Mahmoud R. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia and schizoaffective disorder. Amer J Psychiat 2001; 158: 765–74. 10. Daly J. A short history of evidence-based medicine. Contemporary endocrinology: evidence-based endocrinology. V.Montori (ed.); с. 11–24. 11. Dans AL, Dans LF, Guyatt GH, Richardson WS. User’s guides to the medical literature. XIV. How to decide on the applicability of clinical trial results to your patient. The Evidence Based Medicine Working Group. JAMA 1998; 279 (7): 545–9. 12. Drummond MF, Richardson WS, O’Brien DJ et al. User’s guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. Are the results of the study valid? The Evidence Based Medicine Working Group. JAMA 1997; 277 (19): 1552–7. 13. Evidence Based Medicine Working Group. Evidence based medicine. A new approach to teaching the practice of medicine. JAMA 1992; 268: 2420–5. 14. Fournier JC, De Rubeis RJ, Hollon SD et al. Antidepressant drug effects and depression severity. A patient level meta-analysis. JAMA 2010; 303 (1): 47–53. 15. Grell W, Ludwig-Mayerhofer W, Steller B et al. The recruitment process for a multi-center study on the long-term prophylactic treatment of affective disorders. J Affect Dis 1993; 28: 257–65. 16. Gupta M. Does evidence-based medicine apply to psychiatry? Theoretic Med and Bioethics 2007; 28: 103–20. 17. Guyatt CH, Sackett DL, Cook DJ. User’s guides to the medical literature. How to use an article about therapy or prevention. Are the results of the study valid? The Evidence Based Medicine Working Group. JAMA 1993; 270 (21): 2598–601. 18. Guyatt CH, Sackett DL, Cook DJ. User’s guides to the medical literature. How to use an article about therapy or prevention. What were the results and will they help me in caring for my patients? The Evidence Based Medicine Working Group. JAMA 1994; 271 (1): 59–63. 19. Guyatt CH, Sackett DL, Sinciair JC et al. User’s guides to the medical literature. A method for grading health care recommendations. The Evidence Based Medicine Working Group. JAMA 1995; 274 (22): 1800–4. 20. Guyatt CH, Naylor CD, Juniler E et al. User’s guides to the medical literature. How to use an article about health-related quality of life. The Evidence Based Medicine Working Group. JAMA 1997; 277 (15): 1232–7. 21. Hayward RS, Wilson MC, Tunis SR et al. User’s guides to the medical literature. How to use a clinical practice guidelines. Are the results of the recommendations valid? The Evidence Based Medicine Working Group. JAMA 1995; 274 (7): 570–4. 22. Healy D. Evidence based psychiatry? Psychiat Bull 2001; 25: 290–1. 23. Heres S, Davis J, Maino K et al. Why olanzapine beats risperidone, risperidone beats quetiapine, quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second generation of antipsychotics. Amer J Psychiat 2006; 163: 185–94. 24. Hofmann SG, Barlow DH, Papp LA et al. Pretreatment attrition in a comparative treatment outcome study of panic disorder. Amer J Psychiat 1998; 155: 43–7. 25. Jaeschke R, Guyatt CH, Sackett DL. User’s guides to the medical literature. How to use an article about a diagnostic test. Are the results of the study valid? The Evidence Based Medicine Working Group. JAMA 1994; 271 (5): 389–91. 26. Jaeschke R, Guyatt CH, Sackett DL. User’s guides to the medical literature. How to use an article about a diagnostic test. What are the results and will they help me in caring for my patients? The Evidence Based Medicine Working Group. JAMA 1994; 271 (9): 703–7. 27. Kermen R, Hickner J, Brody H, Hasham I. Family physician believe the placebo effect is therapeutic but often use real drug as placebo. Family Med 2010; 42 (9): 636–42. 28. Khan A, Leventhal RM, Khan SR. Severity of depression and response of antidepressants and placebo: an analysis of the Food and Drug Administration database. J Clin Psychopharmacol 2002; 22: 40–5. 29. Kirsch I, Deacon BJ, Huedo-Medina TB et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5 (2): e45. 30. Kobak KA, Kane JM, Thase ME, Nierenberg AA. Why do clinical trials fail? J Clin Psychopharmacol 2007; 27 (1): 1–5. 31. Kobak KA, Leuchter A, De Brota D et al. Site vs centralized rater in a clinical depression trial. J Clin Psychopharmacol 2010; 30: 193–7. 32. Komossa K, Rummel-Kluge C, Hunger H et al. Sertindole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2009; 2. CD 006752. 33. Komossa K, Rummel-Kluge C, Schmid F et al. Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2009; 4. CD 006569. 34. Komossa K, Rummel-Kluge C, Hunger H et al. Ziprasidone versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2009; 4. CD 006627. 35. Komossa K, Rummel-Kluge C, Hunger H et al. Amisulpride versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2010; 1. CD 006624. 36. Komossa K, Rummel-Kluge C, Schmid F et al. Quetiapine vs other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2010; 1. CD 006625. 37. Komossa K, Rummel-Kluge C, Hunger H et al. Olanzapine vs other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2010; 3. CD 006654. 38. Komossa K, Rummel-Kluge C, Schwarz S et al. Risperidone versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2011; 1. CD 006626. 39. Laupacis A, Wells G, Richardson WS, Tugwell P. User’s guides to the medical literature. How to use an article about prognosis? The Evidence Based Medicine Working Group. JAMA 1994; 272 (3): 234–7. 40. Leucht S, Arbter D, Engel RR et al. How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Mol Psychiat 2008; 14 (4): 429–47. 41. Leucht S, Komossa K, Rummel-Kluge C et al. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiat 2009; 166 (2): 152–63. 42. Levine M, Walter S, Lee H et al. User’s guides to the medical literature. How to use an article about harm? The Evidence Based Medicine Working Group. JAMA 1994; 271 (20): 1615–9. 43. Licht RW, Couliaev G, Vestergaard P et al. Generalisability of results from randomised drug trials: a trial on antimanic treatment. Br J Psychiat 1997; 170: 264–7. 44. Naylor CD, Guyatt GH. User’s guides to the medical literature. How to use an article about a clinical utilization review. The Evidence Based Medicine Working Group. JAMA 1996; 275 (18): 1435–9. 45. O’Brien DJ, Heyland D, Richardson WS et al. User’s guides to the medical literature. How to use an article on economic analysis of clinical practice. What are the results and will they help me in caring for my patients? The Evidence Based Medicine Working Group. JAMA 1997; 277 (22): 1802–6. 46. Overall JE, Gorham DR. The brief psychiatric rating scale. Psycholog Report 1962; 10: 799–812. 47. Oxman AD, Sackett DL, Guyatt CH. User’s guides to the medical literature. How to get started. The Evidence Based Medicine Working Group. JAMA 1993; 270 (17): 2093–5. 48. Oxman AD, Cook DJ, Guyatt CH. User’s guides to the medical literature. How to use an overview. The Evidence Based Medicine Working Group. JAMA 1994; 272 (17): 1367–71. 49. Partonen T, Silvo S, Lonnqvist JK. Patients excluded from an antidepressant efficacy trial. J Clin Psychiat 1996; 57: 572–5. 50. Richardson WS, Detsky AS. User’s guides to the medical literature. How to use a clinical decision analysis. Are the results of the study valid? The Evidence Based Medicine Working Group. JAMA 1995; 273 (16): 1292–5. 51. Richardson WS, Detsky AS. User’s guides to the medical literature. How to use a clinical decision analysis. What are the results and will they help me in caring for my patients? The Evidence Based Medicine Working Group. JAMA 1995; 273 (20): 1610–3. 52. Riedel M, Strassing M, Muller N et al. How representative of everyday clinical populations are schizophrenia patient enrolled in clinical trials? Eur Arch Psychiat Clin Neurosci 2005; 255: 143–8. 53. Sackett DL, Rosenberg WM, Gray JA et al. Evidence based medicine: what it is and what it isn’t. BMJ 1996; 312 (7023): 71–2. 54. Sharp IR, Kobak KA, Osman DA. The use of videoconferencing with patients with psychosis: a review of the literature. Ann Gen Psychiat 2011; 10: 14–24. 55. Sherman R, Hickner J. Academic physicians use placebo in clinical practice and believe in the mind-body connection. J Gen Int Med 2006; 23 (1): 7–10. 56. Subramanian S, Rummel-Kluge C, Hunger H et al. Zotepine vs other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2010; 10. CD 006628. 57. Tandon R, Nasrallah H, Keshavan MS. Shizophrenia, just the facts. Treatment and prevention. Past, present and future. Schizophr Res 2010; 122: 1–23. 58. Tran PV, Hamilton SH, Kuntz AJ et al. Double-blind comparison of olanzapine vs risperidone in the treatment of schizophrenia and other psychotic disorder. J Clin Psychopharmacol 1997; 17: 407–18. 59. Treves TA, Verchovsky R, Klimovitsky R, Korchin AD. Recruitment rate to drug trials for dementia of Alzheimer type. Alzheimer Dis Assos Dis 2000; 14 (4): 209–11. 60. User’s guides to the medical literature. How to use an article reporting variations in the outcomes of health service. The Evidence Based Medicine Working Group. JAMA 1996; 275 (7): 554–8. 61. Wilson MC, Hayward RS, Tunis SR et al. User’s guides to the medical literature. How to use a clinical practice guidelines. What are the recommendations and will they help me in caring for your patients? The Evidence Based Medicine Working Group. JAMA 1995; 274 (20): 1630–2. 62. Woods SW, Zieldonis DM, Sernyak MJ et al. Characteristics of participants and nonparticipants in medication trials for treatment of schizophrenia. Psychiat Serv 2000; 51 (1): 79–84. 63. Zullino D, Conus Ph, Borgeat F, Bonsack C. Readiness to participate in psychiatric research. Can J Psychiat 2003; 48: 480–4.